AB 1460

  • California Assembly Bill
  • 2025-2026 Regular Session
  • Introduced in Assembly Feb 21, 2025
  • Passed Assembly May 19, 2025
  • Senate
  • Governor

Prescription drug pricing.

Bill Subjects

Prescriptiondrugpricing

Abstract

Existing federal law requires the United States Secretary of Health and Human Services to enter into an agreement with each manufacturer of covered outpatient drugs to ensure the amount a covered entity is required to pay for those drugs does not exceed the average manufacturer price of the drug under the federal Medicaid program. Existing state law requires a covered entity to dispense only drugs subject to these federal pricing requirements to Medi-Cal beneficiaries. Existing law prohibits a pharmacy benefit manager from discriminating against a covered entity or its pharmacy in connection with dispensing a drug subject to federal pricing requirements or preventing a covered entity from retaining the benefit of discounted pricing for those drugs. This bill would prohibit a prescription drug manufacturer from engaging in discriminatory practices that would impose additional conditions, prohibit, restrict, deny, or interfere with a qualifying nonhospital 340B community clinic's purchase or delivery of a drug subject to federal pricing requirements if the qualifying nonhospital 340B community clinic utilizes a specified pharmacy, including a contract pharmacy, that dispenses the drug to an eligible patient of the qualifying nonhospital 340B community clinic. The bill would define "discriminatory practices" and "qualifying nonhospital 340B community clinic" for these purposes. The bill would require qualifying nonhospital 340B community clinics to annually perform specified activities to ensure compliance with program rules and guidance from the federal Health Resources and Services Administration. The bill would make related intent statements.

Bill Sponsors (4)

Votes


Actions


Jul 16, 2025

Senate

In committee: Hearing postponed by committee.

Jul 02, 2025

Senate

In committee: Set, second hearing. Hearing canceled at the request of author.

Jun 27, 2025

Senate

From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.

  • Amendment-Introduction
  • Amendment-Passage
  • Reading-1
  • Reading-2
  • Referral-Committee
Com. on HEALTH.

Jun 25, 2025

Senate

In committee: Set, first hearing. Hearing canceled at the request of author.

May 28, 2025

Senate

Referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

May 20, 2025

Senate

In Senate. Read first time. To Com. on RLS. for assignment.

May 19, 2025

Assembly

Read third time. Passed. Ordered to the Senate. (Ayes 44. Noes 6. Page 1589.)

Apr 28, 2025

Assembly

Read second time. Ordered to third reading.

Apr 24, 2025

Assembly

Read second time and amended. Ordered returned to second reading.

Apr 23, 2025

Assembly

From committee: Amend, and do pass as amended. (Ayes 9. Noes 4.) (April 22).

Mar 24, 2025

Assembly

Referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

Feb 24, 2025

Assembly

Read first time.

Feb 22, 2025

Assembly

From printer. May be heard in committee March 24.

Feb 21, 2025

Assembly

Introduced. To print.

Bill Text

Bill Text Versions Format
AB1460 HTML
02/21/25 - Introduced PDF
04/24/25 - Amended Assembly PDF
06/27/25 - Amended Senate PDF

Related Documents

Document Format
04/18/25- Assembly Health PDF
04/30/25- ASSEMBLY FLOOR ANALYSIS PDF
07/14/25- Senate Health PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the California State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.